chemotherapy: be given in form

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be given in form 1.00
is given 0.90
be given in combination 0.83
be given through line 0.82
be given in tablet form 0.80
be given through central line 0.79
be given in cycles 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.47
Rule weight: 0.66
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.34
Plausible(agent, be given in combination)
Evidence: 0.23
¬ Typical(chemotherapy, be given in form)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.80
Similarity weight: 0.83
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.34
¬ Plausible(agent, be given in combination)

Remarkability exclusitivity betweem a parent and a child

0.09
Rule weight: 0.58
Evidence weight: 0.19
Similarity weight: 0.83
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
Evidence: 0.90
¬ Remarkable(agent, be given in combination)

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.23
Similarity weight: 0.90
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
Evidence: 0.86
¬ Remarkable(dialysis, is given)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.83
Evidence: 0.34
Plausible(agent, be given in combination)
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.41
¬ Plausible(chemotherapy, be given in form)

Remarkability from sibling implausibility

0.52
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.90
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.86
Remarkable(dialysis, is given)
Evidence: 0.44
¬ Plausible(dialysis, is given)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.62
Similarity weight: 1.00
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.64
¬ Salient(chemotherapy, be given in form)

Similarity expansion

0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.07
¬ Typical(chemotherapy, is given)
0.69
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.90
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.95
¬ Remarkable(chemotherapy, is given)
0.68
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.08
¬ Remarkable(chemotherapy, be given in tablet form)
0.67
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.07
¬ Typical(chemotherapy, be given in combination)
0.66
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.56
¬ Remarkable(chemotherapy, be given through line)
0.65
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.80
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.12
¬ Salient(chemotherapy, be given in tablet form)
0.64
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.83
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.97
¬ Remarkable(chemotherapy, be given in combination)
0.64
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.51
¬ Remarkable(chemotherapy, be given through central line)
0.64
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.29
¬ Plausible(chemotherapy, is given)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.90
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.54
¬ Salient(chemotherapy, is given)
0.60
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.90
Remarkable(chemotherapy, be given in form)
Evidence: 0.60
¬ Remarkable(chemotherapy, be given in cycles)
0.59
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.83
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.29
¬ Plausible(chemotherapy, be given in combination)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.82
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.48
¬ Salient(chemotherapy, be given through line)
0.57
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.75
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.31
¬ Salient(chemotherapy, be given in cycles)
0.57
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.83
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.57
¬ Salient(chemotherapy, be given in combination)
0.55
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.75
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.25
¬ Plausible(chemotherapy, be given in cycles)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.56
¬ Salient(chemotherapy, be given through central line)
0.54
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.75
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.22
¬ Typical(chemotherapy, be given in cycles)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.46
¬ Plausible(chemotherapy, be given through line)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.80
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.38
¬ Typical(chemotherapy, be given in tablet form)
0.48
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.80
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.51
¬ Plausible(chemotherapy, be given in tablet form)
0.46
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.79
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.54
¬ Plausible(chemotherapy, be given through central line)
0.44
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.49
¬ Typical(chemotherapy, be given through line)
0.36
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.79
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.61
¬ Typical(chemotherapy, be given through central line)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.64
Salient(chemotherapy, be given in form)
Evidence: 0.23
¬ Typical(chemotherapy, be given in form)
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.41
Plausible(chemotherapy, be given in form)
Evidence: 0.23
¬ Typical(chemotherapy, be given in form)

Typicality and Rermarkability incompatibility between a parent and a child

0.37
Rule weight: 0.51
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
Evidence: 0.14
¬ Typical(agent, be given in combination)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.74
Similarity weight: 0.90
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
Evidence: 0.29
¬ Typical(dialysis, is given)

Typicality inheritance from parent to child

0.36
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 0.83
Evidence: 0.23
Typical(chemotherapy, be given in form)
Evidence: 0.14
¬ Typical(agent, be given in combination)